Literature DB >> 6174718

An investigation into the origin and nature of 'amyloid' in a calcifying epithelial odontogenic tumour.

C D Franklin, M V Martin, A Clark, C J Smith, M O Hindle.   

Abstract

Fresh and fixed tissue from a resection specimen of a calcifying epithelial odontogenic tumour (CEOT) was prepared for histological, histochemical, immunological and biochemical investigation in order to study the nature of the amyloid-like material. The fixed tissue gave positive reactions with Congo-red, Thioflavin T and the dimethylamino benzene (DMAB)-method for tryptophan. The diazotization-coupling (DC) method for tyrosine was negative. The major protein purified from the unfixed tissue by sequential gel filtration had a molecular weight of 9,800. The amino acid analysis of this protein had similarities with tuft enamel protein, immune amyloid and the variable light chain component (VK). From the data obtained in this study, it is not possible to determine the precise nature of the amyloid-like material in this CEOT. However, the results do support the concept that 'amyloid' should be considered as a term describing a broad group of related proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174718     DOI: 10.1111/j.1600-0714.1981.tb01293.x

Source DB:  PubMed          Journal:  J Oral Pathol        ISSN: 0300-9777


  4 in total

1.  [Calcifying epithelial odontogenic tumor of the maxilla (Pindborg tumor)].

Authors:  L Li; K T Jäkel; R E Friedrich
Journal:  Mund Kiefer Gesichtschir       Date:  2004-01-24

2.  Calcifying epithelial odontogenic tumor: an immunohistochemical case study.

Authors:  Sopee Poomsawat; Jirapa Punyasingh
Journal:  J Mol Histol       Date:  2007-02-22       Impact factor: 2.611

3.  Pindborg tumor.

Authors:  Santhosh Kumar Caliaperoumal; S Gowri; J Dinakar
Journal:  Contemp Clin Dent       Date:  2016 Jan-Mar

4.  Accumulation of amyloid beta in human glioblastomas.

Authors:  A Zayas-Santiago; A Díaz-García; R Nuñez-Rodríguez; M Inyushin
Journal:  Clin Exp Immunol       Date:  2020-08-11       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.